|
Private Placement (Details 1) (USD $)
|
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Jun. 24, 2014
|
Dec. 31, 2013
|
Jun. 30, 2014
|
|
| Private Placement [Line Items] | |||
| Aggregate fair value | $ 6,277,000 | $ 0 | |
|
Consulting Warrant [Member]
|
|||
| Private Placement [Line Items] | |||
| Stock price on valuation date | $ 14.69 | $ 1.68 | |
| Exercise price | $ 0.04 | $ 0.04 | |
| Term (years) | 3 years 10 months 20 days | 4 years 4 months 17 days | |
| Expected volatility | 60.00% | 60.00% | |
| Dividend yield | 0.00% | 0.00% | |
| Weighted average risk-free interest rate | 1.33% | 1.75% | |
| Number of warrants | 278,228 | 278,228 | |
| Number of trials | 20,000 | 20,000 | |
| Aggregate fair value | 4,019,000 | 529,000 | |
|
Financing Warrant [Member]
|
|||
| Private Placement [Line Items] | |||
| Stock price on valuation date | $ 14.69 | $ 1.68 | |
| Exercise price | $ 3.60 | $ 2.49 | $ 3.60 |
| Term (years) | 3 years 10 months 20 days | 4 years 4 months 17 days | |
| Expected volatility | 60.00% | 60.00% | |
| Dividend yield | 0.00% | 0.00% | |
| Weighted average risk-free interest rate | 1.33% | 1.75% | |
| Number of warrants | 152,778 | 220,905 | |
| Number of trials | 20,000 | 20,000 | |
| Aggregate fair value | $ 1,733,000 | $ 175,000 |
| X | ||||||||||
|
- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Agreed upon price for the exchange of the underlying asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Risk-free interest rate assumption used in valuing an instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the number of trials used in measurement of fair values. No definition available.
|
| X | ||||||||||
|
- Definition
Represents number of warrants used in measurement of fair values. No definition available.
|
| X | ||||||||||
|
- Details
|